F. Gómez

2.1k total citations
30 papers, 1.0k citations indexed

About

F. Gómez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, F. Gómez has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Surgery. Recurrent topics in F. Gómez's work include Respiratory Support and Mechanisms (7 papers), Intensive Care Unit Cognitive Disorders (5 papers) and Renal cell carcinoma treatment (3 papers). F. Gómez is often cited by papers focused on Respiratory Support and Mechanisms (7 papers), Intensive Care Unit Cognitive Disorders (5 papers) and Renal cell carcinoma treatment (3 papers). F. Gómez collaborates with scholars based in France, Spain and United States. F. Gómez's co-authors include C. Carrié, X. Montbarbon, A. d’Hombres, P. Pommier, Marie Pierre Sunyach, Christine Chevreau, Sylvie Négrier, Bernard Escudier, Alain Ravaud and Jean‐Yves Douillard and has published in prestigious journals such as Journal of Clinical Oncology, Critical Care Medicine and British Journal of Cancer.

In The Last Decade

F. Gómez

24 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Gómez France	13	411	322	236	174	164	30	1.0k
Rajesh Bandekar United States	19	377 0.9×	405 1.3×	262 1.1×	273 1.6×	67 0.4×	48	1.3k
Tao Jin China	18	289 0.7×	288 0.9×	203 0.9×	271 1.6×	127 0.8×	73	1.0k
Μohammad Mohammadianpanah Iran	19	254 0.6×	535 1.7×	92 0.4×	374 2.1×	206 1.3×	135	1.3k
Silke Cameron Germany	20	513 1.2×	239 0.7×	219 0.9×	423 2.4×	100 0.6×	76	1.2k
Hiroshi Osawa Japan	19	210 0.5×	124 0.4×	241 1.0×	205 1.2×	173 1.1×	120	1.2k
Stuart Osborne Switzerland	19	359 0.9×	919 2.9×	139 0.6×	319 1.8×	52 0.3×	56	1.7k
Hye Sung Won South Korea	22	289 0.7×	519 1.6×	376 1.6×	227 1.3×	120 0.7×	88	1.3k
Sung‐Hyun Kim South Korea	17	223 0.5×	371 1.2×	213 0.9×	136 0.8×	77 0.5×	105	1.0k
B.K. Mohanti India	15	320 0.8×	252 0.8×	211 0.9×	305 1.8×	64 0.4×	58	994
Hyun Ju Kim South Korea	16	169 0.4×	355 1.1×	299 1.3×	250 1.4×	191 1.2×	50	1.2k

Countries citing papers authored by F. Gómez

Since Specialization

Citations

This map shows the geographic impact of F. Gómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Gómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Gómez more than expected).

Fields of papers citing papers by F. Gómez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Gómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Gómez. The network helps show where F. Gómez may publish in the future.

Co-authorship network of co-authors of F. Gómez

This figure shows the co-authorship network connecting the top 25 collaborators of F. Gómez. A scholar is included among the top collaborators of F. Gómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Gómez. F. Gómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gómez, F., et al.. (2025). The role of extracorporeal CO2 removal from pathophysiology to clinical applications with focus on potential combination with RRT: an expert opinion document. Frontiers in Medicine. 12. 1651213–1651213.

Gómez, F., et al.. (2024). Switches in non-invasive respiratory support strategies during acute hypoxemic respiratory failure: Need to monitoring from a retrospective observational study. Medicina Intensiva. 48(4). 200–210.

Hernández, Gonzalo, J. Soto, Oriol Caritg, et al.. (2024). Effect of aggressive vs conservative screening and confirmatory test on time to extubation among patients at low or intermediate risk: a randomized clinical trial. Intensive Care Medicine. 50(2). 258–267. 14 indexed citations

Gómez, F., Ferran Roche‐Campo, Stefano Italiano, et al.. (2024). Time course of electrical activity of the diaphragm (EAdi) in the peri extubation period and its role as predictor of extubation failure in difficult to wean patients. Critical Care. 28(1). 308–308.

Gómez, F.. (2023). Impact of a Non-Invasive Respiratory Support Strategy and Switches in Therapy During Acute Respiratory Failure Due to SARS-COV-2. 6(4). 1 indexed citations

Gómez, F., et al.. (2022). History of mental disorder in an ICU and referrals to psychiatry. Medicina Intensiva (English Edition). 46(10). 559–567. 1 indexed citations

Pommier, P., et al.. (2013). Curiethérapie : valorisation et aspects médico-économiques. Cancer/Radiothérapie. 17(2). 178–181. 3 indexed citations

Olive, M. Foster, F. Gómez, Anne‐Marie Schott, et al.. (2011). Analyse critique des données du PMSI pour l’épidémiologie des cancers : une approche longitudinale devient possible. Revue d Épidémiologie et de Santé Publique. 59(1). 53–58. 27 indexed citations

Remontet, Laurent, N. Mitton, Chantal Marie Couris, et al.. (2008). Is it possible to estimate the incidence of breast cancer from medico-administrative databases?. European Journal of Epidemiology. 23(10). 681–688. 30 indexed citations

10.

Lotz, Jean‐Pierre, B. Bui, F. Gómez, et al.. (2005). Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial. Annals of Oncology. 16(3). 411–418. 39 indexed citations

11.

Barrueco, M., et al.. (2003). Demoras diagnósticas en el cáncer de pulmón. Archivos de Bronconeumología. 39(10). 437–441. 24 indexed citations

12.

Négrier, Sylvie, Bernard Escudier, F. Gómez, et al.. (2002). Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie. Annals of Oncology. 13(9). 1460–1468. 273 indexed citations

13.

Bennouna, Jaafar, R. Delva, F. Gómez, et al.. (2002). A Phase II Study with 5-Fluorouracil, Folinic Acid and Oxaliplatin (FOLFOX-4 Regimen) in Patients with Metastatic Renal Cell Carcinoma. Oncology. 64(1). 25–27. 12 indexed citations

14.

Bachelot, Thomas, F. Gómez, Pierre Biron, et al.. (2002). A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients. British Journal of Cancer. 87(10). 1079–1085. 2 indexed citations

15.

Gómez, F., et al.. (2002). Efficacy and safety of oral sildenafil citrate (Viagra®) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study. International Journal of Impotence Research. 14(S2). S42–S47. 14 indexed citations

16.

Frappaz, Didier, et al.. (2000). Metaiodobenzylguanidine assessment of metastatic neuroblastoma: Observer dependency and chemosensitivity evaluation. Medical and Pediatric Oncology. 34(4). 237–241. 30 indexed citations

17.

Gómez, F., et al.. (1999). Estudios sobre el niño desnutrido. VII. El volumen sanguíneo y el del plasma en el preescolar desnutrido. Boletín Médico del Hospital Infantil de México. 56(3). 198–201.

18.

Carrié, C., S. Hoffstetter, F. Gómez, et al.. (1999). Impact of targeting deviations on outcome in medulloblastoma: study of the French society of pediatric oncology (SFOP)11Participating institutions including more than one patient: Centre Paul Papin—Angers (M. Mege); Bruxelles (C. De Vriendt); Centre Claudius Regaud—Toulouse (F. Soum); Hôpital Charles Nicolle—Rouen (S. Seng); Institut Jean Godinot—Reims (X. Panis); Hôpital Bellevue—Saint-Etienne (T. Schmitt).. International Journal of Radiation Oncology*Biology*Physics. 45(2). 435–439. 112 indexed citations

19.

Guglielmi, Cesare, F. Gómez, Thierry Philip, et al.. (1998). Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.. Journal of Clinical Oncology. 16(10). 3264–3269. 115 indexed citations

20.

Ravaud, Alain, B. Audhuy, F. Gómez, et al.. (1998). Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie.. Journal of Clinical Oncology. 16(8). 2728–2732. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact